Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Leukemia, Myeloid, Acute 44Myelodysplastic Syndromes 39Lymphoma, Non-Hodgkin 34Lymphoma 32Leukemia 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Hodgkin Disease 19Leukemia, Lymphocytic, Chronic, B-Cell 17Burkitt Lymphoma 15Multiple Myeloma 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Biphenotypic, Acute 12Leukemia, Myeloid, Accelerated Phase 11Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10Hematologic Neoplasms 10Dendritic Cell Sarcoma, Interdigitating 10Blast Crisis 10Lymphoma, Mantle-Cell 9Myeloproliferative Disorders 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Chronic-Phase 8Graft vs Host Disease 8Anemia, Refractory, with Excess of Blasts 8Leukemia, Myelomonocytic, Juvenile 7Congenital Abnormalities 7Recurrence 6Lymphoma, Large-Cell, Anaplastic 6Waldenstrom Macroglobulinemia 5

Interventions

Cyclophosphamide 2tanespimycin 1entinostat 1Vorinostat 1Thiotepa 1Thalidomide 1SUB1 protein, human 1Ritonavir 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Nicotine 1Indinavir 1Filgrastim 1Fentanyl 1Etoposide 1Docetaxel 1Cryosurgery 1Cisplatin 1Chemotherapy, Adjuvant 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × Thiotepa × Lymphoid × Clear all
NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡